Stock Taper Net Sales: $364.5 million, up 5.9% as reported and 4.2% on a currency-neutral basis year-over-year.
Adjusted Gross Profit Margin: 39.5%, an increase of 208 basis points from Q3 2024, driven by favorable pricing and product mix, along with manufacturing efficiencies.
Adjusted Operating Income: $54.1 million, up 24.5% year-over-year.
Adjusted EBITDA: $66.2 million, compared to $53.7 million in Q3 2024.
Adjusted Earnings Per Share: $0.61, a 27% increase from $0.48 in Q3 2024.
Operating Cash Flow: $76.7 million; liquidity at $482 million.
Net Debt: $120.4 million with a net leverage ratio of 0.6x.
Sales Growth: Continued strength in the Americas and EAAA regions, with a 4% increase in currency-neutral net sales across both areas.
Market Segments:
Health care billings surged by 29%.
Corporate office billings rose by 5%.
Education segment slightly declined by 2.5% but remains up year-to-date.
One Interface Strategy: The unified sales approach has improved customer experience and driven growth, particularly in the Nora Rubber segment, which grew 20% in Q3.
Innovation and Automation: Investments in automation and robotics are enhancing productivity and efficiency, with plans to extend these systems to European and Australian facilities.
Product Launches: Introduction of new carpet tile collections and resilient products aimed at expanding market reach and addressing diverse customer needs.
Full-Year Guidance: Increased expectations for net sales to $1.375 billion - $1.390 billion, with an adjusted gross profit margin target of 38.5%.
Capital Expenditures: Expected to rise to $45 million in 2026, with a focus on automation and productivity initiatives.
Tariff Impact: Tariffs diluted adjusted gross profit margin by approximately 30 basis points in Q3, with a projected 50 basis point dilution for Q4.
Education Segment Decline: Slight decrease in education billings raises concerns about timing and market dynamics, though management remains optimistic about long-term growth.
Macro Environment: Challenges noted in Europe, with potential impacts on order momentum in that region.
Sales Outperformance: Health care was highlighted as a key driver of sales outperformance, with strong execution by the One Interface teams.
Future Margin Expansion: Management indicated potential for further margin improvements through productivity and volume leverage, while balancing competitive pricing strategies.
Tax Rate Fluctuations: A significant non-cash tax adjustment due to changes in German tax legislation affected Q3 results, but the adjusted effective tax rate guidance remains unchanged at 26%.
Stock Buyback Strategy: The stock repurchase program is opportunistic, with a focus on maintaining investment in growth and innovation while returning capital to shareholders. Overall, Interface reported a strong quarter with solid growth across multiple segments, driven by strategic initiatives and operational efficiencies, while also navigating challenges related to tariffs and macroeconomic conditions.
SOURCE: Q3 2025 EARNINGS CALL TRANSCRIPT